Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Sanofi Further Opts Out Of CNS Tie-Up With Voyager

Jun 20 2019

• By Joseph Haas

DealWatch_1200x675

Related Content

Gilead Dives Into Protein Degradation With Nurix Pact

Jun 20 2019

Sanofi/Google Alliance To Apply Big Data To R&D, Commercial And Marketing Operations

Jun 18 2019

Array's Three Value Drivers Align With Pfizer's Three Oncology Pillars In $11.4bn Deal

Jun 18 2019

Sobi Realigns Focus On Late-Stage Hematology & Immunology Assets

Jun 14 2019

Asia Deal Watch: BeiGene And Celgene Exit Their Anti-PD-1 Collaboration

Jun 18 2019

ERS Genomics Completes 45 CRISPR Licensing Deals To Date, Largely For Screening, Discovery

Jun 12 2019

Mereo Makes It Stateside With OncoMed Merger

Dec 05 2018

Related Companies

Sanofi

Voyager Therapeutics, Inc

Neurocrine Biosciences, Inc.

Bristol Myers Squibb Company

Bristol Myers Squibb Company

BeOne Medicines Ltd.

Mereo BioPharma Group plc

OncoMed Pharmaceuticals, Inc.

Ultragenyx Pharmaceutical Inc.

Arcturus Therapeutics Ltd.

Gilead Sciences, Inc.

AbCellera Biologics Inc.

Denovo Biopharma LLC

Orion

Johnson & Johnson

Paragon Biosciences LLC

Catalent, Inc

Genmab A/S

Theramex

TherapeuticsMD Inc.

Knight Therapeutics, Inc.

AstraZeneca PLC

Starpharma Holdings Limited

SIGA Technologies, Inc

Pfizer Inc.

Meridian Medical Technologies Inc.

Nurix Therapeutics, Inc.

Array BioPharma, Inc.

Swedish Orphan Biovitrum AB

ERS Genomics Limited

Additional Topics

Business Strategies Commercial Deals M & A BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window